Multidisciplinary Approach to the Treatment of Obese Adolescents: Effects on Cardiovascular Risk Factors, Inflammatory Profile, and Neuroendocrine Regulation of Energy Balance

Table 1

Prevalence of metabolic disorders associated with obesity.

Variables		Baseline (%)	After therapy (%)	𝑃 value
Metabolic syndrome factors (IDF classification)	Glucose	13	5	<0.001
	Insulin	23	4	<0.001
	Triglyceride	17	7	<0.001
	HDL-cholesterol	42	31	0.30
	Systolic blood pressure	26	5	<0.001
	Diastolic blood pressure	14	2	<0.001
	Waist circumference	62	14	<0.001
MS; NAFLD	Metabolic syndrome	30	2	<0.001
	Nonalcoholic fatty liver disease	33	10	<0.001
Others complications	HOMA-IR	83	40	<0.001
	Hyperleptinemia	75	55	<0.001
	Asthma	16	0	<0.001
	Binge eating	6	2	<0.001

Statistical significance 𝑃≤0.05; HOMA-IR: homeostasis model assessment insulin-index resistance; HLD: high-density lipoprotein; IDF: International Diabetes Federation; MS: metabolic syndrome; NAFLD: nonalcoholic fatty liver disease.